Moderna says its RSV shot is 50% effective across a second season
Moderna says its RSV shot is 50% effective across a second season
NEW YORK, June 26 (Reuters) – Moderna Inc (MRNA.O) respiratory syncytial virus (RSV) shot mRESVIA showed 50% efficacy in preventing RSV after 18 months, the drugmaker said on Wednesday.